Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

229
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
229
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

190
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
190
Vaccinations01:51

Vaccinations

45.2K
Overview
45.2K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

305
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
305
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

320
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
320
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

416
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
416

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison between the new Xpert <i>Mycobacterium tuberculosis/</i>Rifampicin (MTB/RIF) Ultra assay and Xpert MTB/RIF for diagnosis of extra-pulmonary tuberculosis in a tertiary care center.

Microbiology spectrum·2025
Same author

Pathomechanisms, genetic insights, and therapeutics in diabetes-associated dementia.

The Journal of endocrinology·2025
Same author

Exploring the impact of waiting time on physical function and psychosocial measures in individuals with lower limb osteoarthritis awaiting orthopaedic consultation.

Journal of health psychology·2025
Same author

Correction: Chavda et al. Peptide-Drug Conjugates: A New Hope for Cancer Management. <i>Molecules</i> 2022, <i>27</i>, 7232.

Molecules (Basel, Switzerland)·2025
Same author

Gating Mechanism for Biased Agonism at Angiotensin II Type 1 Receptors.

Molecules (Basel, Switzerland)·2025
Same author

Control measures for neglected tropical diseases: vaccine updates.

Expert review of vaccines·2025

Related Experiment Video

Updated: Sep 1, 2025

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.1K

Vaccination efforts for Buruli ulcer.

Vivek P Chavda1, Melina Haritopoulou-Sinanidou2, Rajashri Bezbaruah3

  • 1Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad, India.

Expert Review of Vaccines
|August 13, 2022
PubMed
Summary
This summary is machine-generated.

Developing a Buruli ulcer vaccine is crucial due to the disease's severe impact and limited treatment options. Research is progressing, but knowledge gaps remain for effective prevention strategies.

Keywords:
Buruli ulcerMycobacteriumMycobacterium ulceransnecrotizing skin infectiontoxin

More Related Videos

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.7K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.4K

Related Experiment Videos

Last Updated: Sep 1, 2025

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.1K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.7K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.4K

Area of Science:

  • Neglected tropical diseases
  • Mycobacterial infections
  • Vaccinology

Background:

  • Buruli ulcer, caused by *M. ulcerans*, is a debilitating mycobacterial disease prevalent in tropical and subtropical regions.
  • It disproportionately affects impoverished populations, leading to significant health and economic burdens.
  • Current treatments often involve antibiotics and surgery, highlighting the need for alternative interventions.

Purpose of the Study:

  • To review the current progress in developing vaccines for Buruli ulcer.
  • To identify critical knowledge gaps hindering vaccine development for this neglected tropical disease.

Main Methods:

  • Literature review on Buruli ulcer vaccines and immunity.
  • Analysis of existing research on *M. ulcerans* infection and host response.

Main Results:

  • Progress in Buruli ulcer vaccine development is noted.
  • Several knowledge gaps concerning effective vaccination strategies and the role of humoral immunity were identified.

Conclusions:

  • An effective Buruli ulcer vaccine is essential given the disease's severity and lack of noninvasive treatments.
  • Further research is required to understand humoral immunity's role and tailor vaccination strategies for better disease prevention.